NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal ...
A physician who specializes in HIV treatment writes that proposed cuts to an AIDS drug program proposed by the Florida Dept.
4don MSNOpinion
Florida’s proposed cuts to AIDS drug program threaten patient care and public health
More than 128,000 Floridians are living with HIV. The state has the second-highest rate of new HIV diagnoses after Georgia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results